How is coronavirus affecting our operations? Learn more


Diabetes drug slows experimental Parkinson’s disease progression, human trials to begin next year

A new investigational drug, MSDC-0160, originally developed for type 2 diabetes is being readied for human clinical trials in search of the world’s first treatment to impede the progression of Parkinson’s disease following publication of research findings in the journal Science Translational Medicine. “Until now, Parkinson’s treatments have focused on symptom management. If successful in…

Print this page
Back to top